Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study (vol 169, pg 534, 2015)

被引：1
|
作者：
Swords, R. T.
机构：
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2015年 / 171卷 / 02期
关键词：
D O I：
10.1111/bjh.13775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [21] Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia
    Khalife, J.
    Radomska, H. S.
    Santhanam, R.
    Huang, X.
    Neviani, P.
    Saultz, J.
    Wang, H.
    Wu, Y-Z
    Alachkar, H.
    Anghelina, M.
    Dorrance, A.
    Curfman, J.
    Bloomfield, C. D.
    Medeiros, B. C.
    Perrotti, D.
    Lee, L. J.
    Lee, R. J.
    Caligiuri, M. A.
    Pichiorri, F.
    Croce, C. M.
    Garzon, R.
    Guzman, M. L.
    Mendler, J. H.
    Marcucci, G.
    LEUKEMIA, 2015, 29 (10) : 1981 - 1992
  • [22] PEVONEDISTAT, A FIRST-IN-CLASS NEDD8-ACTIVATING ENZYME INHIBITOR, IS A POTENT INHIBITOR OF HEPATITIS B VIRUS
    Sekiba, Kazuma
    Otsuka, Motoyuki
    Koike, Kazuhiko
    GASTROENTEROLOGY, 2019, 156 (06) : S1194 - S1194
  • [23] Preclinical evaluation of MLN4924, the first small molecule inhibitor of NEDD8-activating enzyme (INAE) for the treatment of cancer
    Soucy, Teresa
    Smith, Peter
    Milhollen, Michael
    Berger, Allison
    Davis, Barbara
    Yang, Hua
    Lublinsky, Anya
    Zhang, Julie
    Traore, Tary
    Narayanan, Usha
    Yu, Jie
    Garnsey, James
    Gavin, James
    Weatherhead, Gabriel
    Cullis, Courtney
    Olhava, Edward
    Vyskocil, Stepan
    Rolfe, Mark
    Langston, Steven
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3521S - 3521S
  • [24] Clinical pharmacodynamic assay development for the first small molecule inhibitor of Nedd8-activating enzyme (NAE), MLN4924
    Garnsey, James Joseph
    Walker, Russell M.
    Pickard, Michael D.
    Traore, Tary
    Thomas, Michael
    Zhang, Julie
    Xia, Cindy
    Zhang, Ji
    Mulligan, George
    Smith, Peter G.
    Berger, Allison J.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [25] MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor, Induces Differentiation in Acute Myelogenous Leukemia Cell Lines
    Thomas, M. P.
    Milhollen, M. A.
    Naryanan, U.
    McDonald, A.
    Fleming, M.
    Amidon, B.
    Manfredi, M.
    Smith, P. G.
    Berger, A. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 88 - 88
  • [26] MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, in patients (pts) with metastatic melanoma: Results of a phase I study.
    Bhatia, S.
    Hamid, O.
    Pavlick, A. C.
    Mulligan, G.
    Smith, P. G.
    Pickard, M. D.
    Shultz, M.
    Walker, R. M.
    Dezube, B.
    O'Day, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Discovery of MLN4924, a novel, first in class Nedd8 activating enzyme inhibitor for the treatment of cancer
    Rolfe, Mark
    Milhollen, Michael
    Berger, Allison
    Smith, Pete
    Langston, Steve
    Soucy, Teresa
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3625S - 3626S
  • [28] MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study
    DeAngelo, Daniel J.
    Erba, Harry P.
    Maris, Michael B.
    Swords, Ronan T.
    Anwer, Faiz
    Altman, Jessica K.
    Hua, Zhaowei
    Blakemore, Stephen J.
    Faessel, Helene
    Dezube, Bruce J.
    Medeiros, Bruno C.
    BLOOD, 2013, 122 (21)
  • [29] ACTIVITY OF MLN4924, A NOVEL FIRST IN CLASS SMALL MOLECULE INHIBITOR OF THE NEDD8 ACTIVATING ENZYME, IN PRECLINICAL MODELS OF ACUTE MYELOID LEUKEMIA
    Swords, T.
    Kelly, K.
    Smith, P.
    Mahalingam, D.
    O'Dwyer, M.
    Nawrocki, S.
    Giles, F.
    Carew, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 305 - 306
  • [30] An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924)
    Sumi, Hiroyuki
    Inazuka, Masakazu
    Morimoto, Megumi
    Hibino, Ryosuke
    Hashimoto, Kentaro
    Ishikawa, Tomoyasu
    Kuida, Keisuke
    Smith, Peter G.
    Yoshida, Sei
    Yabuki, Masato
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 480 (03) : 380 - 386
12345